App-Quantinova.ai

Percutaneous Mechanical Thrombectomy for Treatment of Acute Renal and Iliac-artery Thrombosis

Chun-I Wu - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Successful Opening to Recent Thrombotic Occlusion of Arteriovenous Fistula Due to Central Venous Stenosis Using Hybrid Therapy

Hiroki Takenaka - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Catheter-directed Thrombolysis, Iliac and Common Femoral Vein Stenting in May-thurner Syndrome with Refractory Deep Vein Thrombosis

Chiung-Ray Lu - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OFDI Showed Multiple Inter-strut Hollow 9 Months After Very Late Stent Thrombosis in EES in BMS Site Treated with DCB

Yasuhiro Kaetsu - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Everolimus

Very Late Stent Thrombosis Caused by Obvious Very Late Acquired Stent Malapposition Assessed by Optical Coherence Tomography After Everolimus-eluting Stent Implantation into Sirolimus-eluting Stent

Yasunori Yamamoto - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Twelve-month Clinical Outcomes of Transradial Coronary Artery Intervention: Comparison of the Right and Left Radial Artery Approach

Ji Young Park - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Paclitaxel-coated Balloon Versus Paclitaxel-eluting Stent for the Treatment of Diffuse DES In-stent Restenotic Lesions: A Substudy of PEPCAD China ISR Trial

Ye-lin Zhao - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

The Efficacy of Everolimus-eluting Stent (EES) Implantation in Patients with ST-elevation Myocardial Infarction: Outcomes of 2-year Clinical Follow-up

Hideki Yano - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

The Impact of First- Versus Second-generation Drug-eluting Stent on 1-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention

Pyung Chun Oh - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Comparison of PCI Procedure and Outcomes in Patients with STEMI (Differences in TIMI Risk Score)

Hiroya Takafuji - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Safety and Efficacy of a Hybrid Dual Antiplatelet Therapy Regimen for ST-elevation Myocardial Infarction Patients: A Single-centre Experience

Deanna Khoo - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Comparison of Platelet Reactivity and Clinical Outcomes in Patients Treated with Clopidogrel and Coronary Intervention

Sang Yeub Lee - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Observational Studies of Bleeding and Thrombotic Events in Acute Coronary Syndrome Patients Between Different Metabolizer of Clopidogrel

Wen Duo Zhang - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Promising Results of Stent Boost Assisted Modified Minicrush Technique for Treating Bifurcation Lesions

Vithala Surya Prakasa Rao - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Treatment of Bifurcation Lesions with Novel Drug Eluting Self-expandable Stent Axxess: Single Centre First Experience

Farhat Fouladvand - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Umirolimus

Comparison of First versus Second Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Akkala Raghavender Goud - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Diabetes Status on Long-term (6 Years) Outcomes After Percutaneous Coronary Intervention of Left Main Disease: Result from a Real World Experience of 1,528 Consecutive Patients

Ye-lin Zhao - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Benefits of Percutaneous Atrial Septal Defect Occlusion in Patients Older than 60

Yam Hong Wong - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Midterm Clinical and Angiographic Outcomes After Placement of Paclitaxel and Everolimus-eluting Stents for De Novo Native Coronary Stenosis

Tetsuya Ishikawa - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

The Impact of Angiographic Peri-contrast Staining After Second the Impact of Angiographic Peri-contrast Staining After Second Generation DES Implantationeneration DES Implantation

Takahiro Tokuda - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts